Leaflet BERIRAB P solution for intramuscular injection
Indicated for: immunosuppression
Route of administration: intramuscular
Substance: specific rabies immunoglobulin (immunoglobulin)
ATC: J06BB05 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Specific anti-rabies immunoglobulin is used for the prevention of rabies in patients exposed to the rabies virus, such as through bites from suspected animals. It provides passive protection by neutralizing the virus before the body develops an immune response.
The medication is administered intramuscularly, as directed by a doctor, usually in combination with the rabies vaccine. It is important to administer it as soon as possible after exposure.
Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.
Specific anti-rabies immunoglobulin is not recommended for patients with hypersensitivity to human immunoglobulins or severe IgA deficiency.
General data about BERIRAB P
- Substance: specific rabies immunoglobulin
- Date of latest medicines list: 01-07-2013
- Product code: W13474001
- Pharmaceutical form: solution for intramuscular injection
- Quantity: 1
- Product type: Generic medicine
- Prescription status: S - Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.